NKGen Biotech, Inc.
NKGNDelisted Jul 17, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001845459
NKGen Biotech, Inc. was delisted on Jul 17, 2025; its insiders filed their last Form 4 on Jun 2, 2025; no institution reported holding it in 13F filings for Q2 2025; no superinvestor held it.
13F holders, Q1 2025
Institutional positions in NKGen Biotech, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 3
- −22 vs. Q4 2024
- Shares held
- 892.4K
- −7.46M (−89.3%) vs. Q4 2024
- Total value
- $160.8K
- −$4.91M (−96.8%) vs. Q4 2024
- New holders
- 1
- 0 more added
- Sold out
- 23
- 1 more reduced
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NKGN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $165.4K |
| Q1 2026 | 1 | $192.9K |
| Q4 2025 | 1 | $137.8K |
| Q3 2025 | 1 | $303.2K |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 3 | $160.8K |
| Q4 2024 | 25 | $5.07M |
| Q3 2024 | 19 | $1.23M |
| Q2 2024 | 17 | $4.24M |
| Q1 2024 | 13 | $5.66M |
| Q4 2023 | 9 | $13.7M |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding NKGen Biotech, Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Diametric Capital, LP | 518,134 | $93.3K | 0.11% | 00.0% | Unchanged |
| University of Chicago | 325,000 | $58.5K | 0.09% | −225,000−40.9% | Reduced |
| Flow Traders U.S. LLC | 49,220 | $9.00K | 0.00% | +49,220 | New |
| Pathstone Holdings, LLC | 0 | $0 | 0.00% | −2,797,661−100.0% | Sold out |
| Meteora Capital, LLC | 0 | $0 | 0.00% | −2,772,145−100.0% | Sold out |
| Kepos Capital LP | 0 | $0 | 0.00% | −230,022−100.0% | Sold out |
| Vanguard Group Inc | 0 | $0 | 0.00% | −227,804−100.0% | Sold out |
| Sequoia Financial Advisors, LLC | 0 | $0 | 0.00% | −156,000−100.0% | Sold out |
| Magnetar Financial LLC | 0 | $0 | 0.00% | −267,508−100.0% | Sold out |
| Geode Capital Management, LLC | 0 | $0 | 0.00% | −127,168−100.0% | Sold out |
| Advisory Research Inc | 0 | $0 | 0.00% | −43,088−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −33,625−100.0% | Sold out |
| Northern Trust Corp | 0 | $0 | 0.00% | −29,082−100.0% | Sold out |
| Periscope Capital Inc. | 0 | $0 | 0.00% | −25,000−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −22,495−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −22,356−100.0% | Sold out |
| SkyOak Wealth, LLC | 0 | $0 | 0.00% | −13,164−100.0% | Sold out |
| State Street Corp | 0 | $0 | 0.00% | −11,200−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −2,782−100.0% | Sold out |
| BlackRock, Inc. | 0 | $0 | 0.00% | −1,854−100.0% | Sold out |
| SBI Securities Co., Ltd. | 0 | $0 | 0.00% | −902−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −763−100.0% | Sold out |
| Federation des caisses Desjardins du Quebec | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −102−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −45−100.0% | Sold out |
| Polar Asset Management Partners Inc. | 0 | $0 | 0.00% | −500,000−100.0% | Sold out |